Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
ACE2 is an important counterregulatory enzyme in the renin-angiotensin system with potential clinical implications for blood pressure and kidney disease management.
PURPOSE OF REVIEW: Angiotensin-converting enzyme 2 (ACE 2), the main product of which is Ang 1-7, which binds to its receptor, Mas, is an important member of the renin-angiotensin system. RECENT FINDINGS: A substantial body of research indicates that ACE2 is cardioprotective and renoprotective. ACE2 participates in a pathway that is counterregulatory to the effects of angiotensin II (Ang II). The mechanisms by which the protective effects of ACE2 occur are just beginning to be elucidated. SUMMARY: As ACE2 appears to exert protective effects within the kidney and vasculature, recent data indicate that how it is expressed, what regulates it, and how it interacts with other biological systems may ultimately have clinical implications.
No takes yet. Share an insight, caveat, or question.
Julie R. Ingelfinger (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: